Please login to the form below

Not currently logged in
Email:
Password:

Aerie Pharmaceuticals appoints new members of its commercialisation team

David Biddell, Shaun Gentry and Erin Horn join the firm

Eye-disease focused pharmaceutical company Aerie Pharmaceuticals has appointed a trio of new comers to its commercialisation team.

David Biddell joins the US group as its regional sales director for the southeast region, reporting to Gary Menichini who is currently vice president of sales.

Meanwhile, Shaun Gentry and Erin Horn both join from Novartis as directors of national accounts in the market access group.

They will both report to Dale Seibt, who is vice president of market access for North Carolina-based Aerie.

28th November 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Origins Insights

Our goal is to identify and embed transformational patient insights as a fundamental part of the drug development process. As...

Latest intelligence

Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...